191 related articles for article (PubMed ID: 22709571)
1. Genomic characterization of explant tumorgraft models derived from fresh patient tumor tissue.
Monsma DJ; Monks NR; Cherba DM; Dylewski D; Eugster E; Jahn H; Srikanth S; Scott SB; Richardson PJ; Everts RE; Ishkin A; Nikolsky Y; Resau JH; Sigler R; Nickoloff BJ; Webb CP
J Transl Med; 2012 Jun; 10():125. PubMed ID: 22709571
[TBL] [Abstract][Full Text] [Related]
2. Development and characterization of HPV-positive and HPV-negative head and neck squamous cell carcinoma tumorgrafts.
Kimple RJ; Harari PM; Torres AD; Yang RZ; Soriano BJ; Yu M; Armstrong EA; Blitzer GC; Smith MA; Lorenz LD; Lee D; Yang DT; McCulloch TM; Hartig GK; Lambert PF
Clin Cancer Res; 2013 Feb; 19(4):855-64. PubMed ID: 23251001
[TBL] [Abstract][Full Text] [Related]
3. Orthotopic tumorgrafts in nude mice: A new method to study human prostate cancer.
Saar M; Körbel C; Linxweiler J; Jung V; Kamradt J; Hasenfus A; Stöckle M; Unteregger G; Menger MD
Prostate; 2015 Oct; 75(14):1526-37. PubMed ID: 26074274
[TBL] [Abstract][Full Text] [Related]
4. Development and histopathological characterization of tumorgraft models of pancreatic ductal adenocarcinoma.
Garcia PL; Council LN; Christein JD; Arnoletti JP; Heslin MJ; Gamblin TL; Richardson JH; Bjornsti MA; Yoon KJ
PLoS One; 2013; 8(10):e78183. PubMed ID: 24194913
[TBL] [Abstract][Full Text] [Related]
5. Tumorgrafts as in vivo surrogates for women with ovarian cancer.
Weroha SJ; Becker MA; Enderica-Gonzalez S; Harrington SC; Oberg AL; Maurer MJ; Perkins SE; AlHilli M; Butler KA; McKinstry S; Fink S; Jenkins RB; Hou X; Kalli KR; Goodman KM; Sarkaria JN; Karlan BY; Kumar A; Kaufmann SH; Hartmann LC; Haluska P
Clin Cancer Res; 2014 Mar; 20(5):1288-97. PubMed ID: 24398046
[TBL] [Abstract][Full Text] [Related]
6. A validated tumorgraft model reveals activity of dovitinib against renal cell carcinoma.
Sivanand S; Peña-Llopis S; Zhao H; Kucejova B; Spence P; Pavia-Jimenez A; Yamasaki T; McBride DJ; Gillen J; Wolff NC; Morlock L; Lotan Y; Raj GV; Sagalowsky A; Margulis V; Cadeddu JA; Ross MT; Bentley DR; Kabbani W; Xie XJ; Kapur P; Williams NS; Brugarolas J
Sci Transl Med; 2012 Jun; 4(137):137ra75. PubMed ID: 22674553
[TBL] [Abstract][Full Text] [Related]
7. Orthotopic tumorgrafts in nude mice as a model to evaluate calcitriol effects in breast cancer.
Fonseca-Filho VCN; Katayama MLH; Lyra EC; Maria DA; Basso RA; Nonogaki S; Guerra JM; Maistro S; Góes JCGS; Folgueira MAAK
Braz J Biol; 2017 Nov; 77(4):856-867. PubMed ID: 28492801
[TBL] [Abstract][Full Text] [Related]
8. Overview of human primary tumorgraft models: comparisons with traditional oncology preclinical models and the clinical relevance and utility of primary tumorgrafts in basic and translational oncology research.
Lum DH; Matsen C; Welm AL; Welm BE
Curr Protoc Pharmacol; 2012 Dec; Chapter 14():Unit 14.22. PubMed ID: 23258598
[TBL] [Abstract][Full Text] [Related]
9. PD-L1 detection using
Vento J; Mulgaonkar A; Woolford L; Nham K; Christie A; Bagrodia A; de Leon AD; Hannan R; Bowman I; McKay RM; Kapur P; Hao G; Sun X; Brugarolas J
J Immunother Cancer; 2019 Jun; 7(1):144. PubMed ID: 31155004
[TBL] [Abstract][Full Text] [Related]
10. Patient-derived xenografts for individualized care in advanced sarcoma.
Stebbing J; Paz K; Schwartz GK; Wexler LH; Maki R; Pollock RE; Morris R; Cohen R; Shankar A; Blackman G; Harding V; Vasquez D; Krell J; Zacharoulis S; Ciznadija D; Katz A; Sidransky D
Cancer; 2014 Jul; 120(13):2006-15. PubMed ID: 24705963
[TBL] [Abstract][Full Text] [Related]
11. The canary in the coal mine: the growth of patient-derived tumorgrafts in mice predicts clinical recurrence after surgical resection of pancreatic ductal adenocarcinoma.
Thomas RM; Truty MJ; Kim M; Kang Y; Zhang R; Chatterjee D; Katz MH; Fleming JB
Ann Surg Oncol; 2015; 22(6):1884-92. PubMed ID: 25404477
[TBL] [Abstract][Full Text] [Related]
12. Genomic data analysis workflows for tumors from patient-derived xenografts (PDXs): challenges and guidelines.
Woo XY; Srivastava A; Graber JH; Yadav V; Sarsani VK; Simons A; Beane G; Grubb S; Ananda G; Liu R; Stafford G; Chuang JH; Airhart SD; Karuturi RKM; George J; Bult CJ
BMC Med Genomics; 2019 Jul; 12(1):92. PubMed ID: 31262303
[TBL] [Abstract][Full Text] [Related]
13. A multicenter clinical study: personalized medication for advanced gastrointestinal carcinomas with the guidance of patient-derived tumor xenograft (PDTX).
Cheng Y; Qin SK; Li J; Dai GH; Shen BY; Ying JE; Ba Y; Liang H; Wang XB; Xu Y; Zhou L; Ding KF; Qin YR; Yang SJ; Guan WX; Zheng H; Wang Q; Song H; Zhu YP
J Cancer Res Clin Oncol; 2022 Mar; 148(3):673-684. PubMed ID: 33864522
[TBL] [Abstract][Full Text] [Related]
14. Establishment and Characterization of Advanced Penile Cancer Patient-derived Tumor Xenografts: Paving the Way for Personalized Treatments.
Elst L; Van Rompuy AS; Roussel E; Spans L; Vanden Bempt I; Necchi A; Ross J; Jacob JM; Baietti MF; Leucci E; Albersen M
Eur Urol Focus; 2022 Nov; 8(6):1787-1794. PubMed ID: 35537937
[TBL] [Abstract][Full Text] [Related]
15. A pilot clinical study of treatment guided by personalized tumorgrafts in patients with advanced cancer.
Hidalgo M; Bruckheimer E; Rajeshkumar NV; Garrido-Laguna I; De Oliveira E; Rubio-Viqueira B; Strawn S; Wick MJ; Martell J; Sidransky D
Mol Cancer Ther; 2011 Aug; 10(8):1311-6. PubMed ID: 21673092
[TBL] [Abstract][Full Text] [Related]
16. Patient-derived xenografts effectively capture responses to oncology therapy in a heterogeneous cohort of patients with solid tumors.
Izumchenko E; Paz K; Ciznadija D; Sloma I; Katz A; Vasquez-Dunddel D; Ben-Zvi I; Stebbing J; McGuire W; Harris W; Maki R; Gaya A; Bedi A; Zacharoulis S; Ravi R; Wexler LH; Hoque MO; Rodriguez-Galindo C; Pass H; Peled N; Davies A; Morris R; Hidalgo M; Sidransky D
Ann Oncol; 2017 Oct; 28(10):2595-2605. PubMed ID: 28945830
[TBL] [Abstract][Full Text] [Related]
17. An association between successful engraftment of osteosarcoma patient-derived xenografts and clinicopathological findings.
Fortuna-Costa A; Granato RA; Meohas W; Lopes ACS; Caruso AC; Castro E Silva Pinheiro R; d'Eça PDG; Dias RB; Perini JA; Barbosa APF; Moreira de Sá RA; Guimarães JAM; Murray SS; Duarte MEL
Histol Histopathol; 2020 Nov; 35(11):1295-1307. PubMed ID: 32964941
[TBL] [Abstract][Full Text] [Related]
18. Establishing a human renal cell carcinoma tumorgraft platform for preclinical drug testing.
Pavía-Jiménez A; Tcheuyap VT; Brugarolas J
Nat Protoc; 2014 Aug; 9(8):1848-59. PubMed ID: 25010905
[TBL] [Abstract][Full Text] [Related]
19. Colorectal cancer patient-derived xenografted tumors maintain characteristic features of the original tumors.
Cho YB; Hong HK; Choi YL; Oh E; Joo KM; Jin J; Nam DH; Ko YH; Lee WY
J Surg Res; 2014 Apr; 187(2):502-9. PubMed ID: 24332554
[TBL] [Abstract][Full Text] [Related]
20. High IGF-IR activity in triple-negative breast cancer cell lines and tumorgrafts correlates with sensitivity to anti-IGF-IR therapy.
Litzenburger BC; Creighton CJ; Tsimelzon A; Chan BT; Hilsenbeck SG; Wang T; Carboni JM; Gottardis MM; Huang F; Chang JC; Lewis MT; Rimawi MF; Lee AV
Clin Cancer Res; 2011 Apr; 17(8):2314-27. PubMed ID: 21177763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
